Results 21 to 30 of about 1,327,541 (308)
Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whether the impact of liver fibrosis is not fully realized in type 2 diabetes mellitus (T2D) patients with nonalcoholic fatty liver disease (NAFLD), and the ...
Chia-Yen Dai +4 more
doaj +1 more source
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis [PDF]
Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin). The Enhanced Liver Fibrosis (ELF) test consists of an
Julie Parkes +12 more
core +2 more sources
Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
Cholestatic liver disease is a common liver disease in infants and young children. Liver fibrosis is a key factor affecting the prognosis, and liver transplantation is the only treatment option for liver cirrhosis.
Rina Li +8 more
doaj +1 more source
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers [PDF]
Background: Liver fibrosis in human immunodeficiency virus (HIV)-infected individuals is mostly attributable to co-infection with hepatitis B or C. The impact of other risk factors, including prolonged exposure to combined antiretroviral therapy (cART ...
Annika Vermehren +27 more
core +2 more sources
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. [PDF]
Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD.
Richard Schulz +26 more
core +1 more source
Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis [PDF]
Background/aims: There are no data regarding the association between sarcopenic obesity status and nonalcoholic fatty liver disease (NAFLD) and NAFLD-associated liver fibrosis.
박종숙 +4 more
core +1 more source
An altered liver microenvironment characterized by a dysregulated extracellular matrix (ECM) supports the development and progression of hepatocellular carcinoma (HCC). The development of experimental platforms able to reproduce these physio-pathological
Giuseppe Mazza +26 more
doaj +1 more source
(1) Background: This study aimed to correlate the indocyanine green clearance (ICG) test with histopathological grades of liver fibrosis and liver cirrhosis to assess its diagnostic accuracy in differentiating normal liver parenchyma from liver fibrosis ...
Lukas Luerken +9 more
doaj +1 more source
Hepatic fibrosis is a scarring process associated with an increased and altered deposition of extracellular matrix in the liver. It is caused by a variety of stimuli and if fibrosis continues unopposed, it would progress to cirrhosis which poses a significant health problem worldwide.
Ismail Mona, Pinzani Massimo
openaire +3 more sources
Background & Aims: Liver fibrosis/cirrhosis is significant health burden worldwide, resulting in liver failure or cancer and accounting for many deaths each year.
Xiaolei Li +6 more
doaj +1 more source

